Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03138590 · ClinicalTrials.gov registry record · NA
Investigating Accelerated Learning in Healthy Subjects: Trigeminal Nerve Stimulation
A NA study, sponsored by The University of Texas at Dallas.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03138590 is a NA study that was terminated before completion, run by The University of Texas at Dallas. The registered enrollment target is 20 participants.
The verdict
NCT03138590, a NA study, was terminated before completion, sponsored by The University of Texas at Dallas.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether it is possible to accelerate learning and improve associative memory performance in healthy subjects, by applying transcranial Direct Current Stimulation (tDCS) targeting the trigeminal nerve during a verbal paired-associate learning task
Interventions
- DEVICE Transcranial Direct Current Stimulation- Neuroconn DC Stimulator PLUS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-04-04 |
| Est. Completion | 2022-01-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03138590
The ClinicalTrials.gov registry entry for NCT03138590 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas at Dallas, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transcranial Direct Current Stimulation- Neuroconn DC Stimulator PLUS is the first listed.
NCT03138590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03138590 about?
NCT03138590 is a clinical study titled "Investigating Accelerated Learning in Healthy Subjects: Trigeminal Nerve Stimulation". The purpose of this study is to investigate whether it is possible to accelerate learning and improve associative memory performance in healthy subjects, by applying transcranial Direct Current Stimulation (tDCS) targeting the trigeminal nerve during a verbal paired-associate learning task
What is the current status of trial NCT03138590?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2017-04-04. Estimated completion is 2022-01-25.
What interventions are being tested in trial NCT03138590?
The interventions under investigation include: Transcranial Direct Current Stimulation- Neuroconn DC Stimulator PLUS (DEVICE).
Who is sponsoring clinical trial NCT03138590?
This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.